https://www.avient.com/sites/default/files/2022-04/Avient Acquisition of Dyneema and Q1 2022 Results_0.pdf
F I RS T Q UART E R 2022 RE S U LT S $123 $136 2021 2022 $0.89 $0.99 2021 2022 Q1 2022 PERFORMANCE (TOTAL COMPANY) 4 $1,162 $1,294 2021 2022 + 11% (+ 14% excluding FX) Adjusted EPS + 11% (+ 15% excluding FX) + 11% (+ 16% excluding FX) (in millions) (in millions) Sales Adjusted Operating Income Q1 2022 SEGMENT PERFORMANCE 5 CAI $609 $650 Sales ($ in millions) SEM Distribution $89 $95 Operating Income + 7% (+ 10% excluding FX) $363 $433 Sales $24 $24 Operating Income + 19% Flat (1) $217 $245 Sales $34 $40 Operating Income + 7% (+ 11% excluding FX) + 13% (+ 17% excluding FX) + 18% (+ 20% excluding FX) Q1 2021 $1,162 $123 Sustainable Solutions 19 8% 7 Healthcare 32 21% 6 Composites (excl.
Morgan • New Senior Secured Term Loan B and new Senior Unsecured Notes • Potential proceeds from sale of Distribution business modeled to pay off 5.25% senior notes due 2023 and Term Loan • Acquisition aligned with Avient’s track record of disciplined capital allocation policy • Existing dividend policy maintained, focus on deleveraging in the near term (1) (1) Pro forma for the acquisition of Dyneema® and potential divestiture of Distribution, including repayment of senior notes due 2023 and Term Loan Cash and Cash Equivalents 595$ Senior Secured Term Loan due 2026 605$ New Senior Secured Term Loan B 500 Total Senior Secured Debt 1,105$ Senior Unsecured Notes due 2025 650$ New Senior Unsecured Notes 740 Total Senior Unsecured Debt 1,390$ Total Debt 2,495$ Net Debt 1,900$ 2022 Pro forma Adjusted EBITDA 660$ Net Debt / Adjusted EBITDA 2.9x Pro Forma Capitalization (2022 estimates, all figures in $M) TWO-YEAR LEVERAGE GOAL 24 3.5x 2.7x 1.7x 2.9x 2.5x 2.2x 2019PF 2020PF 2022E 2022PF 2023E 2024E Dyneema® AcquisitionClariant Color Acquisition (1) Pro forma for the acquisition of the Clariant Color business (2) Pro forma for the acquisition of Dyneema® and potential divestiture of Distribution, including repayment of senior notes due 2023 and Term Loan (1) (1) (2) 25 PRO FORMA MODELING 2022E Pro Forma Pro Forma ($M) w/ Dyneema w/Sale Revenue 5,100$ 415$ 5,515$ (1,775)$ 3,740$ Adjusted EBITDA 635 130 765 (105) 660 EBITDA % 12% 31% 14% 6% 18% Pro Forma EPS (Adjusted) 3.50$ 0.00$ 3.50$ (0.56)$ 2.94$ Pro Forma EPS (excl. amortization) 3.96$ 0.35$ 4.31$ (0.56)$ 3.75$ Leverage (12/31/2022E) Net Debt / Adjusted EBITDA 1.7x 3.5x 2.9x Avient Dyneema Distribution® ® OUR SPECIALTY JOURNEY ACQUISITION HISTORY 27 Commercial Resources(1) Operating Income ($ in millions) Operating Margins 259 360 At Acquisition 2021 $40 $122 At Acquisition 2021 9% 21% At Acquisition 2021 Established Acquisitions (> 7 years) + 39% + 210% + 1200 bps (1) Commercial Resources include associate headcount in R&D / Technical, Marketing and Sales CLARIANT COLOR ACQUISITION 28 $133 $205 2019PF 2021 28 Clariant Color EBITDA Growth Purchase Price Multiple 10.8x 7.0x 6.1x 2019PF 2021 2021 w/ Full Synergies • Acquisition of Clariant Color business significantly expanded presence in healthcare, packaging and consumer end markets • Strength of portfolio – double-digit annual EBITDA growth since acquisition • $54 million of synergies realized in 2021 • Acquisition completed on July 1, 2020 for $1.45 billion.
Three Months Ended March 31, 2022 Reconciliation to Condensed Consolidated Statements of Income GAAP Results Special Items Adjusted Results Operating Income $ 128.6 $ 7.8 $ 136.4 Income before income taxes $ 111.1 $ 7.7 $ 118.8 Income tax expense - GAAP (26.6) — (26.6) Income tax impact of special items — (2.0) (2.0) Tax adjustments — 1.5 1.5 Net income attributable to noncontrolling interests (0.3) — (0.3) Net income attributable to Avient shareholders $ 84.2 $ 7.2 $ 91.4 EPS $ 0.91 0.08 $ 0.99 Weighted-average diluted shares 92.3 92.3 92.3 1 Three Months Ended March 31, 2021 Reconciliation to Condensed Consolidated Statements of Income GAAP Results Special Items Adjusted Results Operating Income $ 120.4 $ 2.4 $ 122.8 Income before income taxes $ 102.6 $ 2.4 $ 105.0 Income tax expense - GAAP (22.9) — (22.9) Income tax impact of special items — (0.9) (0.9) Tax adjustments — 1.1 1.1 Net income attributable to noncontrolling interests (0.4) — (0.4) Net income attributable to Avient shareholders $ 79.3 $ 2.6 $ 81.9 EPS $ 0.86 0.03 $ 0.89 Weighted-average diluted shares 92.2 92.2 92.2 Year Ended December 31, 2021 Reconciliation to Condensed Consolidated Statements of Income GAAP Results Special Items Adjusted Results Operating income $ 381.2 $ 47.8 $ 429.0 Income from continuing operations before income taxes $ 304.6 $ 57.1 $ 361.7 Income tax expense - GAAP (74.0) — (74.0) Income tax impact of special items — (13.0) (13.0) Tax adjustments — 5.9 5.9 Net income attributable to noncontrolling interests 0.2 — 0.2 Net income from continuing operations attributable to Avient shareholders $ 230.8 $ 50.0 $ 280.8 EPS $ 2.51 0.54 $ 3.05 Weighted-average diluted shares 92.1 92.1 92.1 2 Reconciliation of EBITDA by Segment Three Months Ended March 31, Year Ended December 31, 2022 2021 2021 Operating income: Color, Additives and Inks $ 94.5 $ 88.8 $ 303.1 Specialty Engineered Materials 39.7 34.2 132.0 Distribution 24.2 24.0 93.2 Corporate and eliminations (29.8) (26.6) (147.1) Operating income $ 128.6 $ 120.4 $ 381.2 Items below OI in Corporate: Other income, net $ (0.6) $ 1.5 $ (1.3) Depreciation & amortization: Color, Additives and Inks $ 26.0 $ 27.4 $ 105.7 Specialty Engineered Materials 7.8 7.8 31.7 Distribution 0.2 0.2 0.8 Corporate and eliminations 3.8 1.7 7.7 Depreciation & Amortization $ 37.8 $ 37.1 $ 145.9 EBITDA: Color, Additives and Inks $ 120.5 $ 116.2 $ 408.8 Specialty Engineered Materials 47.5 42.0 163.7 Distribution 24.4 24.2 94.0 Corporate and eliminations (26.0) (24.9) (140.7) EBITDA $ 165.8 $ 159.0 $ 525.8 Reconciliation of Sales, Operating Income and EBITDA - Distribution Year Ended December 31, 2006 2011 2016 Sales $ 732.8 $ 996.5 $ 1,071.0 Operating income 19.2 56.0 68.2 Depreciation & amortization 1.5 0.7 0.7 EBITDA $ 20.7 $ 56.7 $ 68.9 3 Three Months Ended March 31, Year Ended December 31, Reconciliation to EBITDA and Adjusted EBITDA: 2022 2021 2021 Net income from continuing operations – GAAP $ 84.5 $ 79.7 $ 230.6 Income tax expense 26.6 22.9 74.0 Interest expense 16.9 19.3 75.3 Depreciation and amortization from continuing operations 37.8 37.1 145.9 EBITDA $ 165.8 $ 159.0 $ 525.8 Special items, before tax 7.7 2.4 57.1 Depreciation and amortization included in special items (2.1) (0.5) (1.7) Adjusted EBITDA $ 171.4 $ 160.9 $ 581.2 4 Masseto IR Presentation - Final.pdf Avient Corporation �specialty Portfolio Transformation Continues with Dyneema Acquisition DISCLAIMER Slide Number 3 Slide Number 4 Slide Number 5 Q1 2022 SALES AND OPERATING INCOME�(Total Company) Slide Number 7 Slide Number 8 Slide Number 9 Slide Number 10 FIT with Four Pillar Strategy Dyneema® overview Slide Number 13 Slide Number 14 Dyneema® in the Value Chain Demand trends Products Avient’s Existing Composites Portfolio Avient’s Composites Portfolio�Sales and Ebitda Distribution Divestiture Considerations Distribution highlights Dyneema® Transaction Overview Capital structure / Leverage Two-Year Leverage Goal Pro forma modeling Our Specialty Journey Acquisition History Clariant Color Acquisition Specialty Transformation 2022 ebitda margins vs. peers Culture and People Our Specialty Journey continues Slide Number 33 Avient Acquisition of Dyneema and Q1 2022 Results.pdf Masseto IR Presentation - 4.19 (515pm) - with attachments.pdf
https://www.avient.com/sites/default/files/2022-02/Versaflex-Handler Housing for Laparoscopic Sealer-Application snapshot.pdf
SURGICAL DEVICE MANUFACTURER H A N D L E H O U S I N G F O R L A P A R O S C O P I C S E A L E R • Excellent adhesion onto PC/ABS • Good aesthetics with soft touch • RoHS, REACH and FDA compliant • Enhanced ergonomics and functionality with improved soft grip • Met performance requirements for wear resistance and colorability • Customized a thermoplastic elastomer (TPE) solution and had with a faster sample response speed than competitor Versaflex™ Overmolding Formulation KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2023-11/Stat-Tech TPE - Cash Machine Tray - Case Study Snapshot.pdf
avient ATM/ CASH MACHINE T R A Y S T R U C T U R E • Excellent stiffness & rigidity • Anti-static, frictional note speed • Excellent dimensional stability • Flame resistance • Service life durability • Provided a solution with permanent antistatic properties • Excellent wear and friction resistance, enhancing durability • Additional performance characteristics of flame resistance and low COF Stat-Tech™ PC custom formulations KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2020-12/case-study-versaflex-ce-clear-phone-case-1.pdf
PHONE CASE BRAND C L E A R P H O N E C A S E S • Optically clear • Non-yellowing • Good stain resistance • Bondable to PC • Formulated a custom solution to enhance stain resistance and tensile strength • Collaborated on application and technical services to help ensure end product maintained optical clarity when texture was added • Provided manufacturing support to reduce scrap • Coordinated across multiple regions for supply continuity and technical support to serve customer’s global needs Versaflex™ CE 3320-80 TPE KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2022-08/reSound Bio -Swimming Goggle-Application Snapshot.pdf
AVIENT SOLUTION SWIMMING GEAR BRAND S W I M G O G G L E G A S K E T A N D N O S E B R I D G E • Bio-content material • Good adhesion to PC • Flexible and comfortable to wear • Easy to process • Customized formulations for a transparent Shore 43A TPE with 40% bio-based content for the gasket and a natural 57A TPE with 30% bio-based content for the nose bridge to meet sustainability and comfort targets • Delivered excellent performance in order to pass strict chlorine, brine, and QUV tests • Offered prompt development and on-site technical services to accelerate commercialization KEY REQUIREMENTS SUSTAINABILITY + SEALING LEARN MORE reSoundTM BIO Thermoplastic Elastomers Copyright © 2022, Avient Corporation.